David Memel, Frank Fee
Metabolon has appointed David Memel as chief medical officer and Frank Fee as CFO. Memel joins Metabolon from Klaipeda Health where he served as managing director. He has also held a variety of commercial, medical, scientific, informatics, and technology leadership positions at Boehringer Ingelheim Pharmaceuticals, Aetna, Roche Diagnostics, Roche Pharmaceuticals, and PeaceHealth. Fee has been with Metabolon since 2011, where he most recently served as senior VP of finance. Before joining Metabolon, he worked in the life sciences practice of Ernst & Young.